Is postoperative adjuvant radiotherapy necessary for patients with esophageal cancer after neoadjuvant chemoradiotherapy?
Radiotherapy-based adjuvant therapy does not significantly improve the prognosis of EC patients after NCRT, although it may provide a survival benefit for patients with cT3-4 tumors in N-stage downstaging.
Authors
- Chanjun Zhen
- Zhi-Guo ZHOU (ORCID: https://orcid.org/0000-0002-5373-8098)
- Yajing Wang (ORCID: https://orcid.org/0000-0001-9364-8532)
- Zhang Ping (ORCID: https://orcid.org/0000-0002-0105-7899)
- Wenwen Bai
- Yibing Liu (ORCID: https://orcid.org/0000-0002-2862-5542)
- Yuhao Su (ORCID: https://orcid.org/0009-0003-2903-6859)
- Qiuying An
- Liyuan Fu (ORCID: https://orcid.org/0000-0002-3189-8656)
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Saudi Medical Journal
- Published
- 2024-09-01
- DOI
- https://doi.org/10.15537/smj.2024.45.9.20240045
- Citations
- 2
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.15